Milatuzumab
Milatuzumab (or hLL1) is an anti-CD74 humanized monoclonal antibody for the treatment of multiple myeloma non-Hodgkin's lymphoma and chronic lymphocytic leukemia. The drug is the first anti-CD74 antibody that has entered into human testing and is currently being studied for the treatment of multiple myeloma. Milatuzumab has received orphan drug designation from the Food and Drug Administration in the United States for the treatment of multiple myeloma and chronic lymphocytic leukemia. Milatuzumab was developed by Immunomedics, Inc, (Morris Plains NJ USA).
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Milatuzumab
Milatuzumab (or hLL1) is an anti-CD74 humanized monoclonal antibody for the treatment of multiple myeloma non-Hodgkin's lymphoma and chronic lymphocytic leukemia. The drug is the first anti-CD74 antibody that has entered into human testing and is currently being studied for the treatment of multiple myeloma. Milatuzumab has received orphan drug designation from the Food and Drug Administration in the United States for the treatment of multiple myeloma and chronic lymphocytic leukemia. Milatuzumab was developed by Immunomedics, Inc, (Morris Plains NJ USA).
has abstract
Milatuzumab (or hLL1) is an an ...... , Inc, (Morris Plains NJ USA).
@en
Milatuzumab è un anticorpo mon ...... get molecolare è l'antigene: .
@it
ميلاتوزوماب هو جسم مضاد وحيد ا ...... وي المتعدد وأورام الدم الأخرى.
@ar
CAS number
899796-83-9
FDA UNII code
2OP4E0GC6V
KEGG
Link from a Wikipage to an external page
Wikipage page ID
19,841,671
page length (characters) of wiki page
Wikipage revision ID
995,960,139
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
KEGG
D08944
@en
mab type
mab
@en
source
zu/o
@en
target
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
458,284,030
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Milatuzumab (or hLL1) is an an ...... , Inc, (Morris Plains NJ USA).
@en
Milatuzumab è un anticorpo mon ...... get molecolare è l'antigene: .
@it
ميلاتوزوماب هو جسم مضاد وحيد ا ...... وي المتعدد وأورام الدم الأخرى.
@ar
label
Milatuzumab
@en
Milatuzumab
@it
ميلاتوزوماب
@ar